botiss maxgraft® granules and blocks

Processed human allograft.

maxgraft® allograft is the safe and established alternative to autologous bone. maxgraft® granules are 100% derived from living donor bone processed under pharmaceutical conditions by the Cells + Tissuebank Austria (C+TBA). It’s the safe and trusted bone regeneration solution most similar to a patient’s own bone and has been shown to deliver strong structural support, rapid bone regeneration, and volume preservation with a high osteoconductive potential.

  • Safety

    Donors accepted only from selected European countries that have successfully transposed Directive 2004/23/EU into national law.

  • Patient comfort

    A true alternative to autologous bone, eliminating donor site complications such as morbidity, infection or post-operative pain.

  • Reliability

    Osteoconductive properties support natural and controlled tissue remodeling.

  • Biofunctionality

    Excellent and quick biological regeneration capability.

  • Longevity

    Storable at room temperature for 5 years (from date of irradiation).

Contact us

Data usage agreement*

Read our privacy policy.

Downloads

Documents

botiss maxgraft® granules and blocks

Biomaterials@Straumann®. Because one option is not enough.
490.271/en/A/00 08/17 05.12.2017 PDF, 802 KB Download

maxgraft®, maxgraft® bonering, maxgraft® bonebuilder

Maxgraft Processed Human Allograft
MXSen-01/2014-08 31.08.2014 PDF, 3 MB Download

When one option is not enough.

Biomaterials@Straumann®
490.118/en/E/00 09/17 23.11.2017 PDF, 4 MB Download
See all resources...

Scientific evidence

No resources found.

Catalogs

Product Catalog 2019

Straumann® BLX Implant System - interactive
450.012/en/B/00 02/19 26.03.2019 PDF, 2 MB Download

International Course Calendar 2019

More than education
490.150/en/C/02 02/19 15.02.2019 PDF, 9 MB Download

DSO Global Courses 2019

Dental Service Organisation
490.483/en/A/01 01/19 23.01.2019 PDF, 15 MB Download

Product Catalog 2018/2019

Straumann International Edition
452.200/en/C/00 07/18 08.08.2018 PDF, 13 MB Download
See all resources...